Eulerpool Terminal
The edge that pays for itself.
Current Xbrane Biopharma forecasts and price targets in August 2026
Ø Analyst Price Targets
11.22 SEK
+11.09 %
Median
11.22 SEK
+11.09 %
Max
11.55 SEK
Min
11.11 SEK
Last Price
10.10 SEK
Buy
4
Hold
1
Sell
0
The average target price for Xbrane Biopharma is 11.22 SEK. (+11.09 % above the current price)
The median price target of Xbrane Biopharma is 11.22 SEK.
Stock analysts from many renowned investment banks are closely examining the Xbrane Biopharma stock. They conclude their professional Xbrane Biopharma stock analyses with a clear recommendation for the Xbrane Biopharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 0 | 3 | 3 | — |
| 2026-02-01 | 4 | 1 | 0 | 11.22 SEK |
| 2026-02-01 | 4 | 1 | 0 | 63.75 SEK |
| 2026-01-01 | 4 | 1 | 0 | 63.75 SEK |
| 2025-12-01 | 4 | 1 | 0 | 63.75 SEK |
| 2025-12-01 | 4 | 1 | 0 | 63.75 SEK |
Xbrane Biopharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Xbrane Biopharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 180.00 M SEK | -39.00 M SEK | -0.08 SEK |
| 2027e | 222.00 M SEK | — | — |
| 2028e | 319.00 M SEK | — | — |